These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Bis(oxyphenylene)benzimidazoles: a novel class of anti-Plasmodium falciparum agents. Mayence A; Vanden Eynde JJ; Kaiser M; Brun R; Yarlett N; Huang TL Bioorg Med Chem; 2011 Dec; 19(24):7493-500. PubMed ID: 22061825 [TBL] [Abstract][Full Text] [Related]
30. Original quinazoline derivatives displaying antiplasmodial properties. Kabri Y; Azas N; Dumètre A; Hutter S; Laget M; Verhaeghe P; Gellis A; Vanelle P Eur J Med Chem; 2010 Feb; 45(2):616-22. PubMed ID: 19926173 [TBL] [Abstract][Full Text] [Related]
31. One-pot, multicomponent synthesis of 2,3-disubstituted quinazolin-ones with potent and selective activity against Toxoplasma gondii. Brown CE; Kong T; Bordón C; Yolken R; Jones-Brando L; McNulty J Bioorg Med Chem Lett; 2018 May; 28(9):1642-1646. PubMed ID: 29598911 [TBL] [Abstract][Full Text] [Related]
32. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. McLeod R; Muench SP; Rafferty JB; Kyle DE; Mui EJ; Kirisits MJ; Mack DG; Roberts CW; Samuel BU; Lyons RE; Dorris M; Milhous WK; Rice DW Int J Parasitol; 2001 Feb; 31(2):109-13. PubMed ID: 11239932 [TBL] [Abstract][Full Text] [Related]
33. Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway. Fletcher S; Lucantoni L; Sykes ML; Jones AJ; Holleran JP; Saliba KJ; Avery VM Parasit Vectors; 2016 Nov; 9(1):589. PubMed ID: 27855724 [TBL] [Abstract][Full Text] [Related]
34. Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica. Boyom FF; Fokou PV; Tchokouaha LR; Spangenberg T; Mfopa AN; Kouipou RM; Mbouna CJ; Donfack VF; Zollo PH Antimicrob Agents Chemother; 2014 Oct; 58(10):5848-54. PubMed ID: 25049259 [TBL] [Abstract][Full Text] [Related]
35. Hydroxylamine and Carboxymethoxylamine Can Inhibit Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178 [No Abstract] [Full Text] [Related]
36. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain. Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321 [TBL] [Abstract][Full Text] [Related]
37. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo. Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961 [TBL] [Abstract][Full Text] [Related]
38. Salicylanilide inhibitors of Toxoplasma gondii. Fomovska A; Wood RD; Mui E; Dubey JP; Ferreira LR; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Welsh WJ; Sommerville C; Woods S; Roberts C; McLeod R J Med Chem; 2012 Oct; 55(19):8375-91. PubMed ID: 22970937 [TBL] [Abstract][Full Text] [Related]
39. Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites. Chua MJ; Robaa D; Skinner-Adams TS; Sippl W; Andrews KT Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):189-193. PubMed ID: 29631126 [TBL] [Abstract][Full Text] [Related]
40. Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity. Stenzel K; Chua MJ; Duffy S; Antonova-Koch Y; Meister S; Hamacher A; Kassack MU; Winzeler E; Avery VM; Kurz T; Andrews KT; Hansen FK ChemMedChem; 2017 Oct; 12(19):1627-1636. PubMed ID: 28812327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]